FLT
Showing 1 - 25 of 705
Advanced Cancers Trial in Houston (PET Scan, FLT)
Active, not recruiting
- Advanced Cancers
- PET Scan
- FLT
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 16, 2022
Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)
Completed
- Pancreatic Adenocarcinoma
- 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
- +3 more
-
Dallas, TexasUT Southwestern Medical Center
Oct 10, 2022
Brain Tumor Trial in Salt Lake City (Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine)
Recruiting
- Brain Tumor
- Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine
-
Salt Lake City, UtahHuntsman Cancer Institute
Oct 6, 2022
Breast Tumor, Metastatic Breast Cancer, Rb+ Breast Cancer Trial in Philadelphia ([18F]FLT, PET/CT, ribociclib)
Active, not recruiting
- Breast Neoplasm
- +2 more
- [18F]FLT
- +3 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Aug 16, 2022
Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)
Not yet recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- XY0206
- Salvage Chemotherapy
- (no location specified)
May 24, 2023
FLT-PET / MRI Brain Mets
Recruiting
- Brain Metastases
- Radionecrosis
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 6, 2022
Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Tampa (Gilteritinib, Vyxeos)
Suspended
- Acute Myeloid Leukemia With FLT3/ITD Mutation
-
Tampa, FloridaMoffitt Cancer Center
Nov 11, 2022
Image, Body, Cervix Cancer Trial in Singapore ([18F]FLT-PET/MRI body scan)
Recruiting
- Image, Body
- Cervix Cancer
- [18F]FLT-PET/MRI body scan
-
Singapore, SingaporeNational Cancer Centre Singapore
Apr 27, 2022
Small Cell Lung Cancer Trial in Copenhagen (FLT-PET, MRI)
Completed
- Small Cell Lung Cancer
- FLT-PET
- MRI
-
Copenhagen, DenmarkDept. of Clinical Physiology, Nuclear Medicine and PET, Rigshosp
May 3, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +5 more
- Anti-CD40 Agonist Monoclonal Antibody CDX-1140
- +3 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Jan 31, 2023
AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)
Not yet recruiting
- AML, Adult
- +4 more
- AzaCITIDine Oral Tablet
- Xospata
-
Amiens, France
- +19 more
Sep 1, 2023
FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia Trial in Wuhan (T cell injection targeting FLT3 chimeric antigen
Recruiting
- FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
- T cell injection targeting FLT3 chimeric antigen receptor
-
Wuhan, Hubei, ChinaUnion Hospital, affiliated with TongJi Medical College, HuaZhong
Jun 20, 2022
Graft Vs Host Disease Trial in Chapel Hill (Fluorothymidine (FLT))
Active, not recruiting
- Graft Vs Host Disease
- Fluorothymidine (FLT)
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Mar 21, 2022
The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD
Recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- Allogeneic Hematopoietic Stem Cell Transplantation
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022
The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or
Recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- Allogeneic Hematopoietic Stem Cell Transplantation
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022
Advanced Cancer Trial in Houston (FLT-PET)
Completed
- Advanced Cancer
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 3, 2022
AML, Adult Trial in Berne (HDM201, Midostaurin)
Terminated
- AML, Adult
-
Berne, SwitzerlandDepartement of Medical Oncology, University Hospital Berne
Oct 3, 2022
Ewing Sarcoma Trial in United States (drug, diagnostic test, other)
Recruiting
- Ewing Sarcoma
- Trabectedin 1 MG [Yondelis]
- +3 more
-
Los Angeles, California
- +5 more
Aug 15, 2022
Non Small Cell Lung Cancer, Lung Cancer Trial in Bronx (drug, biological, radiation)
Recruiting
- Non Small Cell Lung Cancer
- Lung Cancer
- FLT3 Ligand (CDX-301)
- +2 more
-
Bronx, New YorkAlbert Einstein College of Medicine
Jul 18, 2022
Acute Myeloid Leukemia Trial in Wuhan (Fludarabine + Cyclophosphamide + TAA05 Cell Injection)
Recruiting
- Acute Myeloid Leukemia
- Fludarabine + Cyclophosphamide + TAA05 Cell Injection
-
Wuhan, Hubei, ChinaWuhan Union Hospital
Jun 29, 2022
Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)
Recruiting
- Acute Myeloid Leukemia
- CPX-351
- +5 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health of South Florida
Jul 27, 2022
Metastatic Triple Negative Breast Cancer Trial in Dallas (PLD Chemotherapy, CDX-1140, CDX-301)
Recruiting
- Metastatic Triple Negative Breast Cancer
- PLD Chemotherapy
- +2 more
-
Dallas, TexasUT Southwestern Medical Center
Jun 23, 2022
Acute Myeloid Leukemia (AML) Trial in United States (Gilteritinib, Ivosidenib, Enasidenib)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
- Gilteritinib
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Mar 3, 2023
Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)
Not yet recruiting
- Leukemia, Acute Myeloid (AML)
- Clifutinib
- +5 more
- (no location specified)
Oct 16, 2022
Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Gilteritinib 40 MG Oral Tablet
- +4 more
-
Lexington, KentuckyUniversity of Kentucky
Oct 27, 2022